New York State Common Retirement Fund Regenxbio Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Regenxbio Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,746 shares of RGNX stock, worth $158,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,746
Previous 13,746 -0.0%
Holding current value
$158,216
Previous $112,000 17.86%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Oct 08, 2025
SELL
$7.23 - $11.56 $20,967 - $33,524
-2,900 Reduced 17.42%
13,746 $106,000
Q4 2024

Jan 31, 2025
SELL
$7.23 - $11.56 $20,967 - $33,524
-2,900 Reduced 17.42%
13,746 $106,000
Q3 2024

Oct 08, 2025
BUY
$10.49 - $14.39 $30,421 - $41,731
2,900 Added 21.1%
16,646 $174,000
Q2 2024

Oct 08, 2025
BUY
$11.51 - $21.53 $33,379 - $62,437
2,900 Added 21.1%
16,646 $194,000
Q2 2024

Jul 31, 2024
BUY
$11.51 - $21.53 $3,982 - $7,449
346 Added 2.12%
16,646 $195,000
Q1 2024

Oct 08, 2025
BUY
$12.17 - $24.61 $31,082 - $62,853
2,554 Added 18.58%
16,300 $343,000
Q4 2023

Oct 08, 2025
BUY
$12.89 - $20.82 $32,921 - $53,174
2,554 Added 18.58%
16,300 $292,000
Q4 2023

Feb 01, 2024
SELL
$12.89 - $20.82 $5,504 - $8,890
-427 Reduced 2.55%
16,300 $293,000
Q3 2023

Oct 08, 2025
BUY
$16.46 - $19.99 $49,067 - $59,590
2,981 Added 21.69%
16,727 $275,000
Q3 2023

Nov 07, 2023
BUY
$16.46 - $19.99 $2,106 - $2,558
128 Added 0.77%
16,727 $275,000
Q2 2023

Oct 08, 2025
BUY
$17.23 - $21.71 $49,157 - $61,938
2,853 Added 20.76%
16,599 $331,000
Q2 2023

Aug 07, 2023
SELL
$17.23 - $21.71 $129,845 - $163,606
-7,536 Reduced 31.22%
16,599 $332,000
Q1 2023

Oct 08, 2025
SELL
$18.08 - $24.55 $77,870 - $105,736
-4,307 Reduced 15.14%
24,135 $456,000
Q1 2023

May 02, 2023
SELL
$18.08 - $24.55 $77,870 - $105,736
-4,307 Reduced 15.14%
24,135 $456,000
Q4 2022

Oct 08, 2025
BUY
$20.4 - $24.73 $299,798 - $363,432
14,696 Added 106.91%
28,442 $645,000
Q4 2022

Jan 30, 2023
SELL
$20.4 - $24.73 $306 - $370
-15 Reduced 0.05%
28,442 $645,000
Q3 2022

Nov 08, 2022
BUY
$22.29 - $35.04 $1,136 - $1,787
51 Added 0.18%
28,457 $752,000
Q2 2022

Aug 04, 2022
SELL
$19.35 - $35.04 $890 - $1,611
-46 Reduced 0.16%
28,406 $702,000
Q1 2022

May 05, 2022
SELL
$24.62 - $34.31 $344 - $480
-14 Reduced 0.05%
28,452 $944,000
Q4 2021

Feb 02, 2022
SELL
$30.19 - $40.28 $1,811 - $2,416
-60 Reduced 0.21%
28,466 $931,000
Q3 2021

Nov 02, 2021
SELL
$29.09 - $45.68 $212,124 - $333,098
-7,292 Reduced 20.36%
28,526 $1.2 Million
Q2 2021

Aug 02, 2021
BUY
$32.46 - $40.48 $175,868 - $219,320
5,418 Added 17.82%
35,818 $1.39 Million
Q4 2020

Feb 08, 2021
SELL
$26.52 - $49.35 $60,996 - $113,505
-2,300 Reduced 7.03%
30,400 $1.38 Million
Q2 2020

Aug 07, 2020
BUY
$27.75 - $43.44 $74,925 - $117,288
2,700 Added 9.0%
32,700 $1.2 Million
Q4 2019

Feb 05, 2020
SELL
$34.54 - $44.87 $158,884 - $206,402
-4,600 Reduced 13.29%
30,000 $1.23 Million
Q2 2019

Aug 09, 2019
SELL
$42.0 - $59.29 $232,764 - $328,585
-5,542 Reduced 13.81%
34,600 $1.78 Million
Q1 2019

May 08, 2019
BUY
$40.82 - $62.45 $170,260 - $260,478
4,171 Added 11.6%
40,142 $2.3 Million
Q4 2018

Feb 08, 2019
SELL
$39.11 - $75.15 $117,877 - $226,502
-3,014 Reduced 7.73%
35,971 $1.51 Million
Q3 2018

Nov 07, 2018
BUY
$65.0 - $82.15 $467,025 - $590,247
7,185 Added 22.59%
38,985 $2.94 Million
Q2 2018

Aug 10, 2018
BUY
$27.2 - $74.35 $51,680 - $141,265
1,900 Added 6.35%
31,800 $2.28 Million
Q2 2017

Aug 11, 2017
BUY
N/A
29,900
29,900 $591,000

Others Institutions Holding RGNX

# of Institutions
189
Shares Held
44.7M
Call Options Held
138K
Put Options Held
117K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $498M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email